gastric cancer, esophago-gastric junction cancer, esophageal cancer gastric cancer, esophago-gastric junction cancer, esophageal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 years or older at the time of obtaining consent 2. Patients scheduled to undergo laparoscopic or thoracoscopic surgery (including robot-assisted surgery) under general anesthesia for the treatment of gastric cancer, esophago-gastric junction cancer, or esophageal cancer 3. Patients who have received sufficient explanation regarding participation in this study, fully understand it, and have given their consent of their own free will
Exclusion criteria
Exclusion criteria: Here is the English translation of the given text: 1. Patients with a history of gastrectomy or esophagectomy. 2. Patients with a history of upper abdominal surgery or other conditions that make them unsuitable for laparoscopic or thoracoscopic surgery. 3. Patients with a metal allergy. 4. Patients deemed unsuitable as research subjects by the principal investigator or co-investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The feasibility of fluorescent measurement and position identification of Zemex FS Marker using Lumifinder | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Differences in fluorescence intensity due to the location of the lesion and the thickness of either the gastric wall or the esophageal wall 2. Time required for fluorescence measurement and localization 3. Measurement of the oral or anal side margins of the tumor | — |
Contacts
Hokkaido University Hospital